Literature DB >> 28289720

Discerning functional hierarchies of microRNAs in pulmonary hypertension.

Vinny Negi, Stephen Y Chan.   

Abstract

Pulmonary hypertension (PH) is a multifaceted vascular disease where development and severity are determined by both genetic and environmental factors. Over the past decade, there has been an acceleration of the discovery of molecular effectors that mediate PH pathogenesis, including large numbers of microRNA molecules that are expressed in pulmonary vascular cell types and exert system-wide regulatory functions in all aspects of vascular health and disease. Due to the inherent pleiotropy, overlap, and redundancy of these molecules, it has been challenging to define their integrated effects on overall disease manifestation. In this review, we summarize our current understanding of the roles of microRNAs in PH with an emphasis on potential methods to discern the hierarchical motifs governing their multifunctional and interconnected activities. Deciphering this higher order of regulatory structure will be crucial for overcoming the challenges of developing these molecules as biomarkers or therapeutic targets, in isolation or combination.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28289720      PMCID: PMC5333972          DOI: 10.1172/jci.insight.91327

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  128 in total

1.  Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension.

Authors:  Jared M McLendon; Sachindra R Joshi; Jeff Sparks; Majed Matar; Jason G Fewell; Kohtaro Abe; Masahiko Oka; Ivan F McMurtry; William T Gerthoffer
Journal:  J Control Release       Date:  2015-05-13       Impact factor: 9.776

Review 2.  New pharmacotherapy options for pulmonary arterial hypertension.

Authors:  Swanny Perrin; Marie-Camille Chaumais; Caroline O'Connell; David Amar; Laurent Savale; Xavier Jaïs; David Montani; Marc Humbert; Gérald Simonneau; Olivier Sitbon
Journal:  Expert Opin Pharmacother       Date:  2015-08-12       Impact factor: 3.889

3.  MicroRNA-190 regulates hypoxic pulmonary vasoconstriction by targeting a voltage-gated K⁺ channel in arterial smooth muscle cells.

Authors:  Shan-Shan Li; Ya-Juan Ran; Dan-Dan Zhang; Shu-Zhen Li; Daling Zhu
Journal:  J Cell Biochem       Date:  2014-06       Impact factor: 4.429

4.  A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples.

Authors:  Paola Caruso; Yvonne Dempsie; Hannah C Stevens; Robert A McDonald; Lu Long; Ruifang Lu; Kevin White; Kirsty M Mair; John D McClure; Mark Southwood; Paul Upton; Mei Xin; Eva van Rooij; Eric N Olson; Nicholas W Morrell; Margaret R MacLean; Andrew H Baker
Journal:  Circ Res       Date:  2012-06-19       Impact factor: 17.367

5.  Secreted monocytic miR-150 enhances targeted endothelial cell migration.

Authors:  Yujing Zhang; Danqing Liu; Xi Chen; Jing Li; Limin Li; Zhen Bian; Fei Sun; Jiuwei Lu; Yuan Yin; Xing Cai; Qi Sun; Kehui Wang; Yi Ba; Qiang Wang; Dongjin Wang; Junwei Yang; Pingsheng Liu; Tao Xu; Qiao Yan; Junfeng Zhang; Ke Zen; Chen-Yu Zhang
Journal:  Mol Cell       Date:  2010-07-09       Impact factor: 17.970

6.  Safety and efficacy of RNAi therapy for transthyretin amyloidosis.

Authors:  Teresa Coelho; David Adams; Ana Silva; Pierre Lozeron; Philip N Hawkins; Timothy Mant; Javier Perez; Joseph Chiesa; Steve Warrington; Elizabeth Tranter; Malathy Munisamy; Rick Falzone; Jamie Harrop; Jeffrey Cehelsky; Brian R Bettencourt; Mary Geissler; James S Butler; Alfica Sehgal; Rachel E Meyers; Qingmin Chen; Todd Borland; Renta M Hutabarat; Valerie A Clausen; Rene Alvarez; Kevin Fitzgerald; Christina Gamba-Vitalo; Saraswathy V Nochur; Akshay K Vaishnaw; Dinah W Y Sah; Jared A Gollob; Ole B Suhr
Journal:  N Engl J Med       Date:  2013-08-29       Impact factor: 91.245

7.  MicroRNA-103/107 is involved in hypoxia-induced proliferation of pulmonary arterial smooth muscle cells by targeting HIF-1β.

Authors:  Bi Deng; Jie Du; Rong Hu; Ai-Ping Wang; Wei-Hua Wu; Chang-Ping Hu; Yuan-Jian Li; Xiao-Hui Li
Journal:  Life Sci       Date:  2016-01-29       Impact factor: 5.037

8.  MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension.

Authors:  Lin Deng; Francisco J Blanco; Hannah Stevens; Ruifang Lu; Axelle Caudrillier; Martin McBride; John D McClure; Jenny Grant; Matthew Thomas; Maria Frid; Kurt Stenmark; Kevin White; Anita G Seto; Nicholas W Morrell; Angela C Bradshaw; Margaret R MacLean; Andrew H Baker
Journal:  Circ Res       Date:  2015-08-26       Impact factor: 17.367

9.  miR-21/DDAH1 pathway regulates pulmonary vascular responses to hypoxia.

Authors:  Lucio Iannone; Lan Zhao; Olivier Dubois; Lucie Duluc; Christopher J Rhodes; John Wharton; Martin R Wilkins; James Leiper; Beata Wojciak-Stothard
Journal:  Biochem J       Date:  2014-08-15       Impact factor: 3.857

10.  Mir-206 regulates pulmonary artery smooth muscle cell proliferation and differentiation.

Authors:  Samuel Jalali; Gurukumar K Ramanathan; Prasanna Tamarapu Parthasarathy; Salman Aljubran; Lakshmi Galam; Asfiya Yunus; Sara Garcia; Ruan R Cox; Richard F Lockey; Narasaiah Kolliputi
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

View more
  32 in total

1.  MicroRNA-mediated downregulation of K+ channels in pulmonary arterial hypertension.

Authors:  Aleksandra Babicheva; Ramon J Ayon; Tengteng Zhao; Jose F Ek Vitorin; Nicole M Pohl; Aya Yamamura; Hisao Yamamura; Brooke A Quinton; Manqing Ba; Linda Wu; Keeley S Ravellette; Shamin Rahimi; Francesca Balistrieri; Angela Harrington; Rebecca R Vanderpool; Patricia A Thistlethwaite; Ayako Makino; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-09-25       Impact factor: 5.464

2.  Reply: Transforming Growth Factor β1- and Bone Morphogenetic Protein 2/PPARγ-regulated MicroRNAs in Pulmonary Arterial Hypertension.

Authors:  Hyung J Chun; Sebastien Bonnet; Stephen Y Chan
Journal:  Am J Respir Crit Care Med       Date:  2017-11-01       Impact factor: 21.405

3.  Evolving systems biology approaches to understanding non-coding RNAs in pulmonary hypertension.

Authors:  Lloyd D Harvey; Stephen Y Chan
Journal:  J Physiol       Date:  2018-09-02       Impact factor: 5.182

Review 4.  Clinical value of non-coding RNAs in cardiovascular, pulmonary, and muscle diseases.

Authors:  Sébastien Bonnet; Olivier Boucherat; Roxane Paulin; Danchen Wu; Charles C T Hindmarch; Stephen L Archer; Rui Song; Joseph B Moore; Steeve Provencher; Lubo Zhang; Shizuka Uchida
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-04       Impact factor: 4.249

Review 5.  The Search for Disease-Modifying Therapies in Pulmonary Hypertension.

Authors:  Chen-Shan Chen Woodcock; Stephen Y Chan
Journal:  J Cardiovasc Pharmacol Ther       Date:  2019-02-17       Impact factor: 2.457

Review 6.  The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension.

Authors:  Thomas Bertero; Dror Perk; Stephen Y Chan
Journal:  Expert Opin Ther Targets       Date:  2019-05-11       Impact factor: 6.902

Review 7.  Mitochondrial dysfunction and pulmonary hypertension: cause, effect, or both.

Authors:  Jeffrey D Marshall; Isabel Bazan; Yi Zhang; Wassim H Fares; Patty J Lee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-18       Impact factor: 5.464

8.  Long Range Endocrine Delivery of Circulating miR-210 to Endothelium Promotes Pulmonary Hypertension.

Authors:  Jonathan Florentin; Yi-Yin Tai; Thomas Bertero; Partha Dutta; Stephen Y Chan; Jingsi Zhao; Stéphanie Torrino; Lee Ohayon; Tomasz Brzoska; Ying Tang; Jimin Yang; Vinny Negi; Chen-Shan Chen Woodcock; Michael G Risbano; Seyed Mehdi Nouraie; Prithu Sundd
Journal:  Circ Res       Date:  2020-06-04       Impact factor: 17.367

9.  Hypoxia Triggers SENP1 (Sentrin-Specific Protease 1) Modulation of KLF15 (Kruppel-Like Factor 15) and Transcriptional Regulation of Arg2 (Arginase 2) in Pulmonary Endothelium.

Authors:  Deepesh Pandey; Yohei Nomura; Max C Rossberg; Daijiro Hori; Anil Bhatta; Gizem Keceli; Thorsten Leucker; Lakshmi Santhanam; Larissa A Shimoda; Dan Berkowitz; Lewis Romer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-02-22       Impact factor: 8.311

10.  Matrix stiffening induces a pathogenic QKI-miR-7-SRSF1 signaling axis in pulmonary arterial endothelial cells.

Authors:  Chen-Shan Chen Woodcock; Neha Hafeez; Adam Handen; Ying Tang; Lloyd D Harvey; Leonard E Estephan; Gil Speyer; Seungchan Kim; Thomas Bertero; Stephen Y Chan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-02-10       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.